Skeletal Muscle Contraction

SECTION ONE

Foundations of Human Physiology

CHAPTER 8 | SKELETAL MUSCLE CONTRACTION

Muscle Anatomy, Excitation-Contraction Coupling, Force Generation & Aviation Physiology — Objectives 8.1 through 8.10

Skeletal muscle is the biological actuator of the aviation mission — it powers every control input from the stick and rudder pedals, maintains every postural requirement of the cockpit environment, and sustains the Anti-G Straining Maneuver that stands between a aviator and G-induced loss of consciousness. Understanding skeletal muscle physiology is therefore not an academic exercise but an operational foundation. Understanding how muscle contracts, how force is graded and sustained, how fatigue develops, and how different fiber types respond to training and performance demands makes it possible to explain G-tolerance optimization, fatigue management in long-duration operations, and the physiological basis of physical fitness standards for aircrew.

This chapter covers ten objectives: skeletal muscle gross anatomy and the sarcomere (8.1), the proteins of the contractile apparatus (8.2), excitation-contraction coupling from motor neuron to cross-bridge cycle (8.3–8.4), the cross-bridge cycle and molecular mechanism of force generation (8.5), energy sources for muscle contraction (8.6), the mechanics of force grading including motor units and summation (8.7), the length-tension relationship (8.8), muscle fiber types and their properties (8.9), and muscle fatigue mechanisms and aviation-relevant applications (8.10).

Skeletal muscle is the most abundant tissue in the human body, comprising approximately 40–45% of total body weight and providing the force-generating machinery for all voluntary movement. Its architecture is organized hierarchically from the whole-muscle level down to the molecular level, with each level of organization reflecting specific functional requirements for force generation, fatigue resistance, and metabolic efficiency.

Gross Anatomy of Skeletal Muscle

A whole muscle (e.g., the biceps brachii) is enclosed within a fibrous connective tissue sheath called the epimysium. Internal connective tissue partitions (perimysium) divide the muscle into bundles of muscle fibers called fascicles, and a finer connective tissue layer (endomysium) surrounds each individual muscle fiber. This connective tissue scaffolding transmits the contractile force of individual fibers to the tendons and ultimately to the skeletal lever system, and also contains the blood vessels and motor nerve branches that supply the muscle.

The Skeletal Muscle Fiber

Each skeletal muscle fiber is a single multinucleated cell — formed by the fusion of many myoblast precursor cells during development. A muscle fiber is typically 10–100 μm in diameter and ranges in length from a few millimeters (short fascicles) to tens of centimeters (long parallel fibers). The distinctive features of the muscle fiber include:

• Sarcolemma: The cell membrane of the muscle fiber. It conducts action potentials from the neuromuscular junction along the fiber surface. Invaginations of the sarcolemma form the T-tubule system.
• T-tubules (transverse tubules): Deep invaginations of the sarcolemma that penetrate into the interior of the fiber at each A-I band junction (two per sarcomere). T-tubules conduct the action potential depolarization wave from the fiber surface deep into the fiber interior, ensuring synchronous activation of all sarcomeres across the full fiber diameter.
• Sarcoplasmic reticulum (SR): A specialized intracellular smooth endoplasmic reticulum that forms a network surrounding each myofibril. The SR is the primary storage reservoir for Ca²⁺ within the muscle fiber. Its terminal cisternae are the expanded pouches of SR that lie on each side of the T-tubule, forming a structure called the triad (T-tubule flanked by two terminal cisternae). The triad is the site where T-tubule depolarization is coupled to Ca²⁺ release from the SR.
• Myofibrils: Cylindrical contractile organelles (1–2 μm diameter) that run the full length of the muscle fiber, packed in parallel. Each myofibril contains the sarcomeric contractile apparatus. A single muscle fiber may contain hundreds to thousands of myofibrils.
• Mitochondria: Abundant, arranged in parallel between myofibrils and immediately adjacent to the SR. High mitochondrial density in slow (oxidative) fibers; lower density in fast (glycolytic) fibers. Supply ATP for contraction via oxidative phosphorylation.

The Sarcomere: The Structural Unit of Contraction

The sarcomere is the fundamental repeating structural and functional unit of the myofibril — the basic contractile machine. Each myofibril consists of thousands of sarcomeres arranged end-to-end. A sarcomere extends from one Z disk to the next and measures approximately 2.0–2.2 μm at resting length. The alternating dark (A) and light (I) bands visible under the light microscope reflect the precise geometric arrangement of thick (myosin) and thin (actin) filaments within each sarcomere.

Sarcomere Bands and Lines

• Z disk (Z line): Dense protein disc marking the boundary between adjacent sarcomeres. Actin (thin) filaments are anchored to the Z disk, projecting inward from each side into the sarcomere. Alpha-actinin is the primary Z-disk protein that anchors actin. The Z disk provides structural integrity and coordinates the mechanical forces of adjacent sarcomeres.
• I band (Isotropic band): The light-appearing region on each side of the Z disk, containing ONLY thin (actin) filaments (no overlap with myosin). The I band shortens during contraction as thin filaments slide further into the A band.
• A band (Anisotropic band): The dark central region of the sarcomere. Extends the full length of the thick (myosin) filament (~1.6 μm). Contains both thick filaments AND the overlapping regions of thin filaments. The A band DOES NOT CHANGE LENGTH during contraction — this is a key feature of the sliding filament theory (myosin filaments don’t shorten; actin slides past them).
• H zone: A lighter region in the CENTER of the A band where ONLY thick (myosin) filaments exist without thin filament overlap. The H zone NARROWS during contraction as thin filaments slide further into the A band center.
• M line: A fine central line in the middle of the H zone where adjacent myosin filaments are cross-linked by M-protein and creatine kinase. Provides structural stability to the myosin filament array.
• Titin: A giant elastic protein (largest single protein molecule in biology; ~3,500 kDa) that spans from the Z disk to the M line. Titin functions as a molecular spring that provides passive elastic tension when the sarcomere is stretched and prevents the sarcomere from being overstretched. It also guides myosin back to its central position after contraction.

Table 7.1. Sarcomere Components: Composition, Behavior During Contraction, and Function

The contractile machinery of the sarcomere is composed of two classes of protein filaments — thick filaments (myosin) and thin filaments (actin with tropomyosin and troponin) — plus the regulatory proteins that control when contraction is permitted to occur. Understanding these proteins at the molecular level explains why Ca²⁺ is the biochemical trigger for contraction, how the cross-bridge cycle generates force, and how pharmacological agents and toxins interact with the contractile apparatus.

Thick Filaments: Myosin

Each thick filament is composed of approximately 200–300 myosin II molecules, bundled together by their tail regions to form the filament backbone, with their globular head domains protruding outward at regular intervals (every 14.3 nm, with a 120° rotational offset between successive pairs). The myosin molecule is organized as:

• Heavy chains (2): Form the long tail (rod portion) that bundles together to form the thick filament, plus the S1 head domain where ATPase activity and actin binding occur. The tail forms an alpha-helical coiled-coil structure.
• Light chains (4, two per head): Essential and regulatory light chains associated with each myosin head. The regulatory light chains can be phosphorylated (relevant in smooth muscle but a modulatory role in skeletal muscle).
• Myosin head (S1 fragment): The critical functional domain. It contains: (1) the ATPase site that cleaves ATP to provide energy for the power stroke; (2) the actin-binding site that interacts with actin during the cross-bridge cycle; and (3) a lever arm region whose conformational change during the power stroke produces the force that moves actin.

The myosin thick filament has a bare zone in its center (approximately 0.2 μm) where no cross-bridge heads protrude — this central region is where only tails overlap. Cross-bridge heads point in opposite directions from each half of the filament, so they can pull actin filaments from both ends toward the center during contraction.

Thin Filaments: Actin + Tropomyosin + Troponin

Actin (F-Actin)

Filamentous actin (F-actin) is formed by the polymerization of globular actin monomers (G-actin, ~42 kDa each) into a double-stranded helical filament approximately 1 μm long and 8 nm in diameter. Each G-actin monomer has an associated ADP molecule, and collectively these represent the active sites on the actin filament where myosin cross-bridge heads bind to initiate the power stroke. Active sites are staggered on the two strands, providing one active site approximately every 2.7 nm along the filament.

Tropomyosin

Tropomyosin is a rod-shaped protein that winds along the two grooves of the F-actin double helix, with each tropomyosin molecule spanning approximately 7 G-actin subunits (approximately 38.5 nm). In the resting, relaxed muscle (low Ca²⁺), tropomyosin sits in a position that PHYSICALLY BLOCKS the active sites on actin, preventing myosin cross-bridge heads from binding. This steric (mechanical) blocking of actin active sites is the primary mechanism by which muscle is maintained in the relaxed state.

Troponin

Troponin is a regulatory protein complex consisting of three subunits, each with a distinct functional role:

• Troponin T (TnT): The largest subunit. Binds to tropomyosin, anchoring the troponin complex to the thin filament at one end of each tropomyosin molecule.
• Troponin I (TnI): The inhibitory subunit. Binds to actin, helping to hold tropomyosin in the blocking position over the active sites when Ca²⁺ is absent.
• Troponin C (TnC): The calcium-binding subunit. Contains 4 calcium-binding sites (2 high-affinity regulatory sites; 2 structural sites). When Ca²⁺ binds to the regulatory sites on TnC during muscle activation, a conformational change in the troponin complex causes TnI to release actin and allows tropomyosin to shift position, unblocking the active sites on actin and permitting myosin cross-bridge binding.

The troponin-tropomyosin complex is thus the Ca²⁺-sensitive regulatory switch that gates cross-bridge formation: without Ca²⁺ binding to TnC, tropomyosin blocks actin active sites and no force is generated; with Ca²⁺ bound, sites are exposed and contraction can proceed.

Table 7.2. Contractile and Regulatory Proteins of the Sarcomere

The neuromuscular junction (NMJ) is the specialized synapse between a motor neuron and a skeletal muscle fiber — the interface where the nervous system’s electrical command is converted into the chemical signal (acetylcholine) that initiates muscle action potentials and ultimately contraction. Its anatomy and pharmacology are directly relevant to aviation medicine through the actions of neuromuscular blocking agents used in general anesthesia and the mechanism of action of nerve agents.

Anatomy of the Motor End Plate

The NMJ is located approximately at the midpoint of each skeletal muscle fiber. The motor neuron’s axon terminal loses its myelin sheath as it branches to supply individual muscle fibers. At the NMJ, the axon terminal expands into a synaptic bouton that sits in a specialized depression on the muscle fiber surface called the motor end plate. The motor end plate has a complex, folded structure:

• Presynaptic terminal: The motor axon terminal containing approximately 300,000 acetylcholine (ACh) vesicles per end plate. Each vesicle contains approximately 10,000 ACh molecules. Active zones are specialized regions of the presynaptic membrane where vesicles dock and where voltage-gated Ca²⁺ channels are concentrated.
• Synaptic cleft: The 20–50 nm gap between the presynaptic axon terminal and the postsynaptic muscle membrane. The basal lamina of the synaptic cleft contains acetylcholinesterase (AChE) — the enzyme that rapidly hydrolyzes ACh into acetate and choline within approximately 1 ms of release, terminating its action.
• Postsynaptic membrane (muscle motor end plate): The specialized, deeply folded region of the sarcolemma that contains a very high density of nicotinic acetylcholine receptors (nAChR) — approximately 10,000/μm², concentrated at the crests of the junctional folds. The secondary folds increase the membrane area and house voltage-gated Na⁺ channels at the fold depths.

Sequence of Neuromuscular Transmission

• An action potential arrives at the motor neuron axon terminal.
• Presynaptic membrane depolarization opens voltage-gated Ca²⁺ channels at the active zones. Ca²⁺ enters the terminal (intracellular [Ca²⁺] rises from ~0.1 μM to >100 μM locally).
• Ca²⁺ triggers SNARE-mediated vesicle fusion (synaptotagmin Ca²⁺ sensor) and exocytosis of approximately 100–200 ACh vesicles.
• ACh (~1–2 million molecules per action potential) rapidly diffuses across the 20–50 nm synaptic cleft.
• ACh binds to nicotinic nAChR on the motor end plate (muscle-type nAChR: α2βγδ subunit configuration). This ligand-gated ion channel opens, allowing simultaneous inward Na⁺ flow and outward K⁺ flow, with net inward positive charge movement depolarizing the end plate membrane.
• End plate potential (EPP) is generated: a large, graded depolarization (typically 50–70 mV) at the motor end plate. The EPP is not an action potential itself — it is a graded receptor potential.
• The EPP spreads electrotonically to adjacent sarcolemma containing voltage-gated Na⁺ channels. When threshold is reached, a full action potential is initiated in the sarcolemma.
• The muscle fiber action potential propagates bidirectionally along the sarcolemma and down the T-tubule system, initiating Ca²⁺ release from the SR (excitation-contraction coupling, Objective 8.4).
• Simultaneously, AChE in the synaptic cleft hydrolyzes ACh into acetate + choline. Choline is recycled by a high-affinity choline transporter in the presynaptic membrane.

The Neuromuscular Safety Factor

The normal NMJ has a remarkably high safety factor for transmission: each presynaptic action potential releases approximately 3 times the amount of ACh required to trigger a muscle fiber action potential. This means that even if some ACh is lost by diffusion or early hydrolysis, or if some nAChR are blocked, the EPP still exceeds threshold and contraction is initiated.

The high safety factor is clinically important because it means that NMJ disease or pharmacological NMJ blockade must reduce ACh effect by more than approximately 67% before muscle contraction begins to fail. In myasthenia gravis (autoimmune destruction of nAChR), the safety factor is progressively reduced as receptor numbers fall. Initial weakness only appears when >50–70% of receptors are lost, explaining the characteristic fatigable weakness: under normal conditions, transmission succeeds, but with repetitive firing (depleting vesicle availability) the diminished reserve is exposed.

Table 7.3. NMJ Pharmacology and Pathology: Mechanism and Clinical Effect

Excitation-contraction (E-C) coupling is the sequence of molecular events that links the electrical signal of the muscle fiber action potential to the release of Ca²⁺ from the sarcoplasmic reticulum and the initiation of myofilament interaction. It is the bridge between the electrical and mechanical worlds within the muscle fiber — converting a membrane voltage change into a chemical signal (Ca²⁺) that activates the contractile proteins.

E-C Coupling: Step-by-Step Sequence

• The muscle fiber action potential propagates along the sarcolemma and rapidly enters the interior of the fiber via the T-tubule network. Because T-tubules are open to the extracellular space, they allow the electrical depolarization to reach all sarcomeres simultaneously, regardless of fiber diameter.
• Depolarization of the T-tubule membrane activates the dihydropyridine receptor (DHPR) — a voltage-gated Ca²⁺ channel (L-type Ca²⁺ channel) located in the T-tubule membrane at the triad. In skeletal muscle, the DHPR primarily functions as a voltage SENSOR (mechanical transducer) rather than requiring substantial Ca²⁺ entry to function.
• The DHPR voltage sensor undergoes a conformational change in response to T-tubule depolarization and directly activates (via mechanical coupling) the ryanodine receptor (RyR1) in the adjacent terminal cisterna of the SR. RyR1 is a large tetrameric Ca²⁺ release channel embedded in the SR membrane.
• RyR1 opens, allowing massive Ca²⁺ efflux from the SR lumen into the myoplasm. Resting myoplasmic [Ca²⁺] is approximately 10⁻⁷ M (0.1 μM). Upon activation, it rises to approximately 10⁻⁵ M (10 μM) — a 100-fold increase within milliseconds.
• Elevated myoplasmic Ca²⁺ binds to troponin C on the thin filaments, initiating the conformational changes that expose actin active sites and allow cross-bridge formation (detailed in Objective 8.5).
• Muscle contraction proceeds as cross-bridge cycling continues, powered by ATP hydrolysis.
• When the action potential ceases, T-tubule repolarization leads to DHPR conformational restoration → RyR1 closes → Ca²⁺ release from SR stops.
• Simultaneously, the SR Ca²⁺-ATPase (SERCA pump) actively pumps Ca²⁺ back into the SR lumen against its concentration gradient. SERCA activity is modulated by phospholamban (a regulatory protein that inhibits SERCA when unphosphorylated and is released from SERCA when phosphorylated by PKA during sympathetic stimulation). In skeletal muscle, SERCA returns myoplasmic [Ca²⁺] to resting levels within tens to hundreds of milliseconds.
• As [Ca²⁺] falls below approximately 10⁻⁶ M, Ca²⁺ dissociates from TnC → tropomyosin returns to blocking position → cross-bridges cannot re-form → muscle relaxes.

Table 7.4. Components of Excitation-Contraction Coupling in Skeletal Muscle

Differences Between Skeletal and Cardiac E-C Coupling

In skeletal muscle, the DHPR directly activates RyR1 by mechanical (protein-protein) coupling — Ca²⁺ entry through the DHPR is NOT required. In cardiac muscle, the DHPR is a functional Ca²⁺ channel that must allow Ca²⁺ entry (‘trigger Ca²⁺’) from the extracellular space, and this trigger Ca²⁺ then activates the cardiac RyR2 via Ca²⁺-induced Ca²⁺ release (CICR). This difference explains why skeletal muscle can contract normally even in Ca²⁺-free extracellular solution (EC coupling does not require extracellular Ca²⁺) while cardiac muscle cannot.

The cross-bridge cycle is the fundamental molecular event that converts chemical energy (from ATP hydrolysis) into mechanical work (filament sliding). It is a repeating cycle of attachment, force generation, detachment, and resetting that, when occurring asynchronously among hundreds of millions of cross-bridges in a contracting muscle, produces smooth, sustained force generation. Understanding the cross-bridge cycle at this molecular level provides the mechanistic basis for understanding rigor mortis, the energetics of contraction, and how fatigue alters contractile performance.

The Five-Step Cross-Bridge Cycle

Energetics and Rate of the Cross-Bridge Cycle

One ATP molecule is consumed per complete cross-bridge cycle. Each cycle produces approximately 10 nm of filament displacement per cross-bridge. At maximum shortening velocity (Vmax), when the muscle contracts against no load, cross-bridge cycling is at its highest rate. As external load increases, cycling rate decreases (cross-bridges spend more time in the attached, force-bearing state per cycle). At a load equal to the maximum isometric force (Po), velocity approaches zero — the cross-bridges are cycling so slowly that no net shortening occurs, but force is maintained.

Muscle contraction demands continuous ATP supply: each cross-bridge cycle consumes one ATP molecule, and the total cellular ATP pool (~4 mM in muscle fibers) can support maximal contraction for only 1–2 seconds. The muscle maintains ATP concentration near resting levels during all intensities of exercise through three energy systems that are activated in a specific sequence determined by the urgency and duration of the exercise demand. Understanding these energy systems is foundational to understanding exercise physiology, fatigue, training adaptation, and the energetic demands of AGSM and high-performance flight operations.

Energy Source 1: Phosphocreatine (PCr) — The Immediate System

Phosphocreatine (creatine phosphate) is a high-energy phosphate compound that serves as an immediately available reservoir for ATP regeneration. The reaction is catalyzed by creatine kinase (CK):

• PCr + ADP → Creatine + ATP (catalyzed by creatine kinase)

Key characteristics:

• Speed: Instantaneous; PCr transfers its high-energy phosphate to ADP within milliseconds.
• Capacity: Muscle PCr stores are approximately 5× greater than ATP stores. Total ATP + PCr provides approximately 5–8 seconds of maximal contraction.
• Oxygen independence: The PCr reaction requires no oxygen, no mitochondria, and generates no lactate or H⁺. It is the cleanest ATP source.
• Recovery: PCr is resynthesized within 2–8 minutes of recovery (100% recovery in approximately 5–8 minutes with adequate oxygen delivery).
• Primary use: First 1–8 seconds of maximal exercise (sprint start, ballistic movement, initial AGSM effort, explosive power output).

Energy Source 2: Anaerobic Glycolysis — The Short-Term System

Glycolysis is the cytoplasmic breakdown of glucose (from blood) or glycogen (stored in muscle) to pyruvate, generating ATP without requiring oxygen. When oxygen delivery is insufficient for aerobic metabolism (high-intensity exercise) or as an immediate supplement to PCr, glycolysis produces lactate:

• Glucose/Glycogen → Pyruvate → Lactate + 2–3 ATP net per glucose

Key characteristics:

• Speed: Fast; glycolysis can activate within seconds of exercise onset.
• Capacity: Limited by muscle glycogen stores (approximately 300–500 g total body glycogen), H⁺ accumulation (acidosis impairs glycolytic enzymes and TnC Ca²⁺ sensitivity), and Pi accumulation. Approximately 30–90 seconds of maximal effort sustainability.
• Oxygen independence: Pyruvate is converted to lactate (by lactate dehydrogenase) to regenerate NAD⁺, allowing glycolysis to continue without mitochondrial oxidation. Lactate itself is not the cause of fatigue — it is the H⁺ produced simultaneously with lactate that contributes to acidosis.
• Primary use: High-intensity exercise lasting 10 seconds to 2–3 minutes; supplemental ATP during sustained high-G AGSM; sustained power output when aerobic capacity is exceeded.

Energy Source 3: Aerobic Oxidative Phosphorylation — The Long-Term System

Aerobic metabolism in the mitochondria produces ATP from the complete oxidation of carbohydrates, fats, and (to a small extent) proteins. The products are CO₂ and H₂O — no acidosis. The two major pathways:

• Carbohydrate (glucose/glycogen) oxidation: Glucose → pyruvate → acetyl-CoA → TCA cycle + electron transport chain → approximately 30–36 ATP per glucose molecule. Requires O₂. Most efficient substrate at high exercise intensities.
• Fat oxidation (β-oxidation): Fatty acids → acetyl-CoA → TCA cycle + ETC → up to 129 ATP per 18-carbon fatty acid (palmitate = 129 ATP). Requires more O₂ per ATP than carbohydrate but enormous substrate reserve (adipose fat stores can theoretically supply energy for days).

Key characteristics:

• Speed: Slow to fully activate (30–2 minutes to reach steady state depending on exercise intensity).
• Capacity: Virtually unlimited (fat stores) if O₂ delivery is maintained. Carbohydrate stores are limiting at high intensity (glycogen depletion → fatigue within 60–90 minutes of maximal aerobic effort).
• Oxygen dependence: Requires continuous O₂ delivery from the cardiovascular system. Hypoxia at altitude reduces aerobic capacity proportionally to the reduction in PaO₂ and O₂ delivery.
• Primary use: Exercise >2 minutes; sustained aerobic endurance exercise; maintained AGSM during long-duration high-G sorties; recovery of PCr after intense effort.

Table 7.5. Three Energy Systems for Muscle Contraction: Characteristics and Utilization

The single motor neuron does not control a single muscle fiber — it controls a group of fibers collectively called a motor unit. And the force a muscle generates is not all-or-nothing; it is exquisitely graded across an enormous range by two mechanisms that the CNS exploits simultaneously: recruiting additional motor units and increasing the firing frequency of already-active units. Understanding these mechanisms explains how the same muscle can produce force ranging from the delicate control required for instrument landing to the explosive maximal-effort AGSM.

The Motor Unit

A motor unit consists of one α-motoneuron (anterior horn cell) and all the skeletal muscle fibers it innervates. All fibers within a motor unit are of the same fiber type (all slow-twitch or all fast-twitch), are co-activated by every action potential from their motoneuron (they fire together), and contribute force simultaneously. Key features:

• Size: Ranges from 3–10 fibers per motor unit (laryngeal and extraocular muscles — fine motor control) to 500–1,000+ fibers per motor unit (large limb muscles like gastrocnemius — coarse force control). The average motor unit contains approximately 80–150 muscle fibers.
• Motor unit territory: Muscle fibers of a single motor unit are interdigitated (scattered) throughout a region of the muscle, not clustered together. This ensures that contraction is distributed across the muscle cross-section, producing even force development rather than localized cramping.
• Twitch: A single action potential in a motoneuron causes a single, brief contraction of all fibers in its motor unit called a twitch. Twitch duration varies by fiber type: fast-twitch units produce brief twitches (<50 ms total duration); slow-twitch units produce longer twitches (~100–200 ms).

Mechanism 1: Recruitment (Multiple Fiber Summation)

Recruitment is the activation of additional motor units to increase total muscle force. The CNS controls the number of simultaneously active motor units. Recruitment follows the size principle (Henneman’s size principle):

• Small motoneurons (small motor units, slow-twitch fibers) are recruited FIRST: Small α-motoneurons have lower input resistance and are more excitable — they reach threshold with smaller synaptic input from descending motor commands. They innervate small, slow-twitch, fatigue-resistant Type I motor units. These units are recruited for all voluntary muscle activity, regardless of intensity.
• Large motoneurons (large motor units, fast-twitch fibers) are recruited LAST: Large α-motoneurons require much greater synaptic drive to reach threshold. They innervate large, fast-twitch, fatigable Type II motor units. Large motor units are only activated for high-force requirements. A 50× difference in contractile force between the largest and smallest motor units provides enormous range of force control.

Practical implication: During light activity (writing, instrument scanning), only the smallest, most fatigue-resistant motor units are active. As force requirement increases, progressively larger and more powerful (but more fatigable) units are added. During maximal effort (AGSM, emergency egress), all available motor units — including the largest fast-twitch units — are recruited.

Mechanism 2: Frequency Summation and Tetanization

Even after a motor unit is recruited, its force output can be increased by raising the frequency of motoneuron firing — because muscle twitches can summate:

• Twitch: A single action potential → single Ca²⁺ release → single twitch. Force rises, then falls within the twitch duration as Ca²⁺ is recaptured by SERCA.
• Temporal summation (unfused tetanus): If a second action potential arrives before the muscle has fully relaxed from the first twitch, the second Ca²⁺ release adds to residual Ca²⁺, and the second twitch force adds to the residual force from the first. The result is a staircase pattern of increasing force with increasing frequency.
• Fused tetanus (complete tetanic contraction): At sufficiently high frequencies (approximately 50–100 Hz for most skeletal muscle), individual twitches fuse into a smooth, continuous, maximum-force contraction called fused tetanus. Ca²⁺ is continuously released faster than SERCA can recapture it, maintaining near-maximum troponin saturation and cross-bridge formation. Tetanic force is approximately 3–4× greater than a single twitch.
• Treppe (staircase effect): Progressive increase in twitch force with the first several stimuli at low frequency, attributed to increasing residual Ca²⁺ in the myoplasm with each successive contraction.

The force a skeletal muscle can generate is not constant across all lengths — it varies in a predictable, sarcomere-geometry-dependent pattern known as the length-tension relationship. This relationship reflects the physical overlap between actin and myosin filaments within the sarcomere and has profound implications for muscle function in the body, for the design of exercise programs, and for understanding why muscles are most effective at specific joint angles.

The Sarcomere Length-Tension Relationship

The maximum isometric force a muscle can generate depends on the number of cross-bridges that can form, which in turn depends on the degree of overlap between thin (actin) and thick (myosin) filaments at any given sarcomere length. Four regions describe the relationship:

• Plateau (optimal overlap; sarcomere ~2.0–2.2 μm): Maximum cross-bridge formation. All myosin cross-bridge heads can reach actin active sites. Optimal overlap between filaments without any filament compression. Maximum isometric force (100%). This is approximately the resting sarcomere length of most muscles in the body, indicating that evolution has optimized in vivo muscle mechanics.
• Descending limb (stretched; sarcomere 2.2–3.6 μm): As the sarcomere is stretched beyond optimal length, the actin filaments are pulled further away from the myosin cross-bridge heads at the filament ends. Progressively fewer cross-bridges can form (actin moves out of reach of some myosin heads). Force declines linearly as length increases. At sarcomere length ~3.6 μm, no overlap exists and active force is zero.
• Ascending limb (compressed; sarcomere 1.65–2.0 μm): As the sarcomere shortens below optimal, the actin filaments from opposite ends of the sarcomere begin to overlap each other (double overlap), sterically interfering with cross-bridge formation. Additionally, the thick (myosin) filaments begin to contact and crumple against the Z disks. Active force declines progressively. At sarcomere ~1.27 μm, force approaches zero as the sarcomere approaches its physical minimum length.
• Very short lengths (<1.65 μm): Severe structural compression; myosin filaments crumple against Z disks; active force approaches zero.

Passive Tension

In addition to the active (cross-bridge-generated) force, stretched muscles also develop passive tension from the elastic properties of titin (within sarcomeres) and connective tissue (endomysium, perimysium, epimysium) as they are elongated. Passive tension increases steeply at lengths beyond the normal resting length and contributes substantially to total muscle tension at high extension. This passive elasticity is the basis for the muscle’s ability to store and release elastic energy (as in the stretch-shortening cycle used in running and jumping).

Whole-Muscle Length-Tension and Joint Biomechanics

For a whole muscle in the body, the length-tension relationship determines the optimal joint angle for maximum force output. Muscles attached closer to a joint (shorter moment arm) must generate much higher tension than muscles with longer moment arms to produce the same joint torque. The biceps brachii, for example, generates maximum force when the elbow is at approximately 90° — where the combination of sarcomere length (near optimal) and moment arm produces the greatest torque. At full extension or full flexion, both the length-tension relationship and/or the moment arm disadvantage reduce effective torque.

Every skeletal muscle in the human body contains a mixture of fiber types, each optimized for a different functional role. The proportions of these fiber types in a given muscle reflect both the primary function of that muscle and the genetic endowment of the individual, with some capacity for training-induced adaptation. Understanding fiber type properties is essential for interpreting exercise physiology data, understanding fatigue patterns relevant to AGSM and sustained flight operations, and for optimizing physical conditioning recommendations for aircrew.

Type I Fibers: Slow-Twitch Oxidative (Red Muscle)

Type I fibers (also called slow oxidative or SO fibers) are the primary fibers for sustained, low-to-moderate force activities. Their properties are optimized for aerobic metabolism and fatigue resistance:

• Small fiber diameter: Slower diffusion distances for O₂ delivery and metabolic product removal. Smaller motor units.
• Slow myosin ATPase isoform (MHC-I): Slow cross-bridge cycling rate → slow contraction velocity, slow twitch time (~100–200 ms). Generates force slowly but maintains it with less ATP expenditure per unit time.
• High mitochondrial density: Supports high rates of oxidative phosphorylation. Primary ATP source = aerobic.
• High myoglobin content: Myoglobin (muscle hemoglobin; iron-containing protein with even higher O₂ affinity than Hb) stores and facilitates O₂ transport to mitochondria. Gives the fiber its red color (hence ‘red muscle’).
• High capillary density: Maximizes O₂ delivery and metabolic byproduct removal.
• High fatigue resistance: Can sustain contractions for hours without significant fatigue. The soleus (postural muscle) is predominantly Type I and maintains antigravity posture continuously.
• Size principle recruitment: Recruited FIRST for all voluntary activity (even maximal effort begins with Type I activation).

Type II Fibers: Fast-Twitch (White Muscle)

Type II fibers are specialized for high-force, high-speed contractions but at the cost of fatigue resistance. Two main subtypes:

Type IIa (Fast Oxidative-Glycolytic, FOG)

Intermediate between Type I and Type IIx. Moderately fast contraction. High mitochondrial density (more than Type IIx, less than Type I). Moderate fatigue resistance. Well suited for sustained high-intensity activity (distance running pace, sustained AGSM effort). Training can increase Type IIa percentage at the expense of Type IIx.

Type IIx (Fast Glycolytic, FG; also called IIb in some species)

The fastest, most powerful, and most fatigable fiber type in human muscle. Properties:

• Large fiber diameter: Large cross-sectional area generates high absolute force. The largest motor units.
• Fast myosin ATPase isoform (MHC-IIx): Rapid cross-bridge cycling rate → fast contraction velocity, short twitch time (~10–50 ms). 3–5× faster than Type I.
• Low mitochondrial density: ATP production primarily via anaerobic glycolysis.
• High glycolytic enzyme activity: Large stores of glycogen and glycolytic enzymes for rapid ATP production.
• Low myoglobin content: White appearance (‘white muscle’).
• Low fatigue resistance: Fatigue rapidly (seconds to minutes of maximal effort) due to PCr depletion, glycogen depletion, and lactate/H⁺ accumulation.
• Size principle recruitment: Recruited LAST, only for maximal or near-maximal force demands.

Table 7.6. Skeletal Muscle Fiber Type Properties: Type I, IIa, and IIx

Fiber Type Distribution and Training

The proportion of Type I to Type II fibers in a given muscle is largely genetically determined. Elite endurance athletes (marathon runners) may have 70–80% Type I fibers in their major locomotor muscles; elite sprinters and power athletes may have 70–80% Type II fibers. The general population averages approximately 50% Type I / 50% Type II in most limb muscles.

Training can shift fiber subtypes within the Type II category: endurance training shifts Type IIx → Type IIa (increasing oxidative capacity); strength/power training maintains or slightly increases Type IIa and may slow the shift away from IIx. True Type II → Type I conversion does not appear to occur with training in healthy adults (cross-reinnervation with a different motoneuron type can convert fiber type, as shown in animal experiments, but does not occur physiologically in humans through exercise alone).

Muscle fatigue is the exercise-induced reduction in force production capacity — the inability of a muscle to maintain the required or expected force output. Fatigue is not a single mechanism but a complex, multi-site phenomenon with contributions from peripheral (within the muscle fiber) and central (CNS) sources. In aviation, fatigue of the AGSM muscles is a direct determinant of G-tolerance duration, and fatigue of postural and cognitive-support muscles limits extended mission performance. Understanding fatigue at the mechanistic level supports the design of evidence-based conditioning programs and operational guidelines that delay its onset.

Peripheral Fatigue: Within the Muscle

Peripheral fatigue refers to reduced force generation capacity arising within the muscle fiber itself or at the neuromuscular junction. Multiple mechanisms contribute simultaneously during intense exercise:

• Phosphocreatine (PCr) depletion: The immediate ATP buffer is exhausted within 5–10 seconds of maximal effort. Without PCr, the muscle must rely increasingly on glycolysis for ATP, which is slower and produces fatigue-inducing metabolites. PCr depletion is a primary cause of early fatigue in sprint-type and AGSM efforts.
• Inorganic phosphate (Pi) accumulation: Pi released from ATP hydrolysis (and PCr breakdown) accumulates in the myoplasm. Pi inhibits the cross-bridge power stroke by competing with the phosphate binding step (inhibiting Pi release from the myosin head, slowing the power stroke transition in Step 4 of the cross-bridge cycle). Pi also reduces Ca²⁺ sensitivity of the troponin-tropomyosin complex. Pi accumulation is now considered the PRIMARY cause of early power output reduction in skeletal muscle.
• Hydrogen ion (H⁺) accumulation: During rapid anaerobic glycolysis, pyruvate is converted to lactate + H⁺. Intramuscular acidosis (falling pH from ~7.0 to ~6.4 during maximal exercise) impairs multiple processes: reduced Ca²⁺ sensitivity of TnC (higher Ca²⁺ required for the same activation), inhibition of glycolytic enzymes (phosphofructokinase is particularly sensitive), and slowed cross-bridge cycling. Acidosis is a major contributor to fatigue in sustained high-intensity exercise lasting >30–60 seconds.
• Ca²⁺ handling failure: With prolonged exercise, SR Ca²⁺ release may decrease due to elevated Pi (which precipitates as CaHPO₄ within the SR lumen, reducing available releasable Ca²⁺), and SERCA pump activity may be impaired by the acidic pH, slowing reuptake. The net effect is reduced Ca²⁺ transients during each action potential, reducing peak force.
• Glycogen depletion: The primary fuel for high-intensity anaerobic exercise. When muscle glycogen is depleted, glycolysis can no longer maintain ATP regeneration at the required rate. Glycogen depletion is the primary fatigue mechanism during prolonged moderate-to-high intensity endurance exercise (>60–90 minutes).
• Impaired oxygen delivery (hypoxia): At altitude without supplemental oxygen, reduced arterial PO₂ limits mitochondrial ATP production rate, accelerating reliance on anaerobic pathways and causing earlier Pi, H⁺, and lactate accumulation. All peripheral fatigue mechanisms are accelerated by hypoxia.

Central Fatigue: Within the CNS

Central fatigue refers to a reduction in neural drive to the muscle — the CNS reduces the firing rate or number of active motor units before the peripheral muscle has reached its absolute failure limit. Central fatigue appears to be a protective mechanism that prevents catastrophic muscle damage by limiting sustained maximal activation. Key aspects:

• Reduced motoneuron firing rate: During sustained maximal effort, motoneuron firing frequency decreases even before the muscle’s intrinsic force capacity is exhausted. This is thought to reflect both afferent feedback from fatigue-sensing muscle afferents (group III and IV fibers detecting metabolite accumulation and mechanical stress) and intrinsic CNS mechanisms that reduce excitatory drive.
• Perception of effort: The perceived effort required to maintain a given force output increases as peripheral fatigue develops. The CNS increases the motor command intensity to maintain force, and the growing discrepancy between expected and actual force output generates increasing perceived effort — contributing to the subjective experience of fatigue and eventual voluntary task failure.
• Neurotransmitter changes: Prolonged exercise alters central neurotransmitter systems (including serotonin, dopamine, and glutamate) in ways that may reduce neural excitability and increase perceived fatigue. The 'central fatigue hypothesis' proposes that elevated brain serotonin/dopamine ratios during prolonged exercise contribute to central fatigue — a mechanism that branched-chain amino acid supplementation has been proposed to address, with mixed evidence.
• Sleep deprivation and central fatigue: Cumulative sleep deprivation — a common feature of extended aviation operations — dramatically amplifies central fatigue by reducing motoneuron excitability and cognitive support for sustained motor task performance. Sleep-deprived aviators exhibit measurably reduced AGSM effectiveness, reduced grip strength, and reduced sustained attention for physical task performance.

NMJ Fatigue

Under extreme conditions (stimulation rates >100 Hz for several minutes), acetylcholine vesicle depletion at the NMJ can reduce transmission reliability — NMJ fatigue. However, under normal physiological conditions (even during intense exercise), NMJ fatigue is minimal and does not contribute significantly to exercise-induced force reduction. The NMJ safety factor (approximately 3×) provides substantial reserve.

Table 7.7. Mechanisms of Muscle Fatigue: Site, Cause, and Aviation Context